Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPE-CP celecoxib trial in chronic pancreatitis pain
2025-522956-25-00Phase 3Authorised
- Sponsor
- University Hospital Odense
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic pancreatitis (CP) comparing Celecoxib arm with Placebo arm (2 arms). Primary endpoint: Total pain burden over 16 weeks. Planned start May 2026; status: authorised.
02
Drugs
celecoxib
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2025-522956-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522956-25-00.